IVD Medical Holdings Purchases $19 Million in Ether for Treasury
IVD Medical Holdings has acquired $19 million (HK$149 million) worth of ether to enhance its strategy for tokenizing real-world assets.
- IVD is developing the ivd.xyz platform, focusing on pharmaceutical intellectual property and healthcare assets using Ethereum smart contracts.
- The company selected Ethereum due to its maturity, liquidity, and institutional recognition, citing the SEC's approval of a spot ETH ETF.
- ETH will facilitate on-chain ownership verification, automated revenue distribution, and compliance governance for tokenized assets.
- IVD plans to use ETH as the foundation for its IVDD stablecoin to support cross-border transactions compliant with Hong Kong and U.S. regulations.
- Revenue from real-world asset transactions will be converted into ETH and added to IVD's treasury.
- IVD aims to engage in staking and derivatives to increase returns and liquidity while ensuring downside protection.
This initiative aligns IVD with a select group of HKEX-listed firms possessing crypto treasuries, predominantly favoring bitcoin.
IVD's actions are part of a broader collaboration with HashKey Group, which operates the licensed HashKey exchange in Hong Kong.